Patent · US Active

Glucans

US10646506B2 · kind B2 · utility

0Cited by

5References

17Claims

0Family size

Assignee

Biotec Pharmacon Asa · NO

Inventors

Rolf Engstad · Tromsø, NO
Thor Nøkland · Tromsø, NO

Key dates

Filing date	Nov 14, 2016
Grant date	May 12, 2020
Priority date	—
Expiry date	Oct 12, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08B37/0024
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a glucan having a weight average molar mass of 15,000 to 50,000 g/mol on a single chain basis and a weight average molar mass in aqueous solution on an aggregate basis of 4 to 20×105 g/mol and existing in gel form in aqueous solution at a concentration ≥1% at 25° C. and neutral pH and having a melting temperature (gel to sol) of 30 to 44° C. when the glucan is dissolved in water at a concentration of 2%, methods for the production thereof, medical uses thereof, physical supports having the glucan applied thereto or impregnated thereon and in vitro methods of proliferation of skin cells which comprise contacting a population of skin cells with the glucan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.